Mesenchymal GBM (mGBM), the most common subset, expresses the mesenchymal markers Vimentin (Vim) and YKL-40 and demonstrates the most aggressive and angiogenic phenotype [5,6,7,8]. The gene discussed is VIM; the disease is glioblastoma.